• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Medicare Advantage Enrollment Increasing By 10.2% Next Year

Article

CMS says 26.9 million beneficiaries are expected to enroll in Medicare Advantage plans in 2021.

Enrollment in Medicare Advantage has been increasing steadily since the early 2000s and the growth will continue next year, according to figures recently announced by CMS

A CMS press release yesterday said 26.9 million Medicare beneficiaries are expected to enroll in Medicare Advantage plans next year, a 10.2% increase from this year’s enrollment of 24.4 million.

The enrollment increase is consistent with the trend of the growing popularity of Medicare Advantage plans relative to traditional fee-for-service Medicare. Enrollment in Medicare Advantage plans has doubled over the past 10 years, according to the Kaiser Family Foundation’s figures. More than a third of Medicare beneficiaries are now in Medicare Advantage plans.

From "A Dozen Facts About Medicare Advantage in 2020," KFF, April 22, 2020.

The CMS press release also said that the average monthly premium for a Medicare Advantage plan is expected to decrease next year by 11%, from $23.60 this year to an estimated $21 next year.

CMS also reported that the that the average number of Medicare Advantage plan choices on a county-by-county basis is expected to increase next year to 47 plans per county compared with 39 per county this year.

Related Videos
Video 9 -"Overcoming Implementation Barriers for Digital Therapeutics Adoption"
Video 6 - "Failing to Reach Ideal Diabetes Care: Equitable Doesn’t Mean Equal"
Video 5 - "Revising Diabetes Outcome Measures"
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Related Content
© 2024 MJH Life Sciences

All rights reserved.